Back to MedTech Notes
Lesson 1 of 630 min read
Clinical Chemistry
Carbohydrates, Lipids, Proteins, Enzymes, and Organ Function Tests
In This Lesson
1. Carbohydrate Metabolism
Glucose Testing
Diagnostic Criteria
| Test | Normal | Prediabetes | Diabetes |
|---|---|---|---|
| FBS | <100 mg/dL | 100-125 | ≥126 |
| OGTT (2hr) | <140 mg/dL | 140-199 | ≥200 |
| HbA1c | <5.7% | 5.7-6.4% | ≥6.5% |
| Random | - | - | ≥200 + symptoms |
Glucose Methods
Enzymatic Methods
- Glucose Oxidase: Specific for glucose; GOD-POD reaction
- Hexokinase: Reference method; NADPH measured at 340nm
- Glucose Dehydrogenase: Uses NAD/NADP
Interferences
- • Ascorbic acid: False decrease (GOD-POD)
- • Hemolysis: Glycolytic enzymes
- • Lipemia: Turbidity interference
Hemoglobin A1c
- Definition: Glycated hemoglobin; glucose attached to N-terminal valine of beta chain
- Reflects: 2-3 month average blood glucose (RBC lifespan)
- Methods: Ion-exchange chromatography, HPLC, immunoassay
- Interferences: Hemoglobinopathies (HbS, HbC), hemolysis, uremia
- Target: <7% for most diabetics
Hypoglycemia & Hyperglycemia
Hypoglycemia (<70 mg/dL)
- • Insulin overdose
- • Insulinoma
- • Liver failure
- • Alcohol ingestion
- • Addison's disease
Hyperglycemia
- • Diabetes mellitus (Type 1, 2)
- • Pancreatitis
- • Cushing syndrome
- • Stress/trauma
- • Medications (steroids)
2. Lipid Profile
Lipoproteins
Classes (by density)
- Chylomicrons: Largest; dietary TG transport
- VLDL: Endogenous TG; liver origin
- LDL: "Bad" cholesterol; atherogenic
- HDL: "Good" cholesterol; reverse transport
Apolipoproteins
- Apo A-I: Major HDL protein; LCAT activator
- Apo B-100: LDL; LDL receptor ligand
- Apo B-48: Chylomicrons
- Apo E: Remnant clearance
Reference Ranges
Desirable Levels
- Total Cholesterol: <200 mg/dL
- LDL-C: <100 mg/dL (optimal)
- HDL-C: >40 M, >50 F mg/dL
- Triglycerides: <150 mg/dL
Risk Factors
- High LDL → Atherosclerosis
- Low HDL → CVD risk
- High TG (>500) → Pancreatitis
- TC/HDL ratio >4.5 → Risk
Friedewald Equation
LDL = TC - HDL - (TG/5)
- Limitations: Invalid if TG >400 mg/dL or Type III hyperlipidemia
- Specimen: Fasting (10-12 hours) required for TG
- Direct LDL: Homogeneous assays available (no fasting needed)
3. Proteins & Amino Acids
Total Protein & Albumin
- Total Protein: 6.0-8.0 g/dL; Biuret method (purple color)
- Albumin: 3.5-5.0 g/dL; BCG/BCP methods; made in liver
- Globulins: TP - Albumin; includes immunoglobulins
- A/G Ratio: 1.2-2.0; decreased in liver disease, inflammation
Serum Protein Electrophoresis
Fractions (Anode to Cathode)
- Albumin: 60%; transports bilirubin, hormones, drugs
- Alpha-1: AAT, AFP
- Alpha-2: Haptoglobin, Ceruloplasmin
- Beta: Transferrin, C3, LDL
- Gamma: Immunoglobulins (IgG, IgA, IgM, IgD, IgE)
Pattern Recognition:
- • M-spike (monoclonal): Multiple myeloma
- • Polyclonal: Chronic inflammation
- • Beta-gamma bridging: Cirrhosis
4. Enzymes
Enzyme Kinetics
- Michaelis-Menten: V = Vmax[S]/(Km + [S])
- Km: Substrate concentration at 1/2 Vmax; measure of affinity
- Zero-order: Substrate excess; rate = constant
- First-order: Rate proportional to substrate concentration
Clinically Important Enzymes
| Enzyme | Source | Clinical Use |
|---|---|---|
| ALP | Liver, Bone, Intestine | Biliary obstruction, bone disease |
| AST | Heart, Liver, Muscle | Hepatitis, MI (less specific) |
| ALT | Liver (specific) | Hepatitis (most specific liver) |
| GGT | Liver, Kidney | Alcohol, biliary disease |
| LDH | All tissues | Non-specific tissue damage |
| CK | Muscle, Heart, Brain | Muscle damage, MI |
| Amylase/Lipase | Pancreas, Salivary | Pancreatitis |
5. Liver Function Tests
Bilirubin Metabolism
- RBC breakdown → Unconjugated (indirect) bilirubin
- Transported to liver bound to albumin
- Conjugated with glucuronic acid (direct bilirubin)
- Excreted in bile → Urobilinogen → Stercobilin (feces)
Prehepatic
↑ Indirect; Hemolysis
Hepatic
↑ Both; Hepatitis
Posthepatic
↑ Direct; Obstruction
Liver Enzymes Pattern
Hepatocellular (ALT > ALP)
- • Viral hepatitis
- • Drug-induced liver injury
- • Ischemic hepatitis
- • AST:ALT >2 suggests alcohol
Cholestatic (ALP > ALT)
- • Biliary obstruction
- • Primary biliary cholangitis
- • Drug-induced cholestasis
- • GGT confirms hepatic ALP
6. Kidney Function Tests
Markers of Kidney Function
| Test | Reference Range | Notes |
|---|---|---|
| BUN | 7-20 mg/dL | Urea nitrogen; diet, protein intake affect |
| Creatinine | 0.7-1.3 (M), 0.6-1.1 (F) | Muscle mass related; best endogenous marker |
| eGFR | >90 mL/min/1.73m² | CKD-EPI equation; <60 = CKD |
| Cystatin C | 0.6-1.0 mg/L | Not affected by muscle mass |
BUN/Creatinine Ratio
- Normal: 10-20:1
- >20:1 (Prerenal): Dehydration, CHF, GI bleed, high protein
- <10:1 (Intrarenal): Acute tubular necrosis, malnutrition, liver disease
- Normal ratio, both elevated: Postrenal obstruction or intrinsic renal disease
7. Electrolytes & ABG
Major Electrolytes
- Sodium: 136-145 mEq/L; major extracellular cation
- Potassium: 3.5-5.0 mEq/L; major intracellular cation
- Chloride: 98-106 mEq/L; follows sodium
- Bicarbonate: 22-28 mEq/L; buffer system
- Calcium: 8.5-10.5 mg/dL total; 4.5-5.5 ionized
- Magnesium: 1.8-2.4 mg/dL
Anion Gap
AG = Na - (Cl + HCO3)
- Normal: 8-12 mEq/L
- High AG acidosis (MUDPILES): Methanol, Uremia, DKA, Propylene glycol, INH/Iron, Lactic acidosis, Ethylene glycol, Salicylates
Arterial Blood Gas
- pH: 7.35-7.45
- pCO2: 35-45 mmHg (respiratory component)
- HCO3: 22-28 mEq/L (metabolic component)
- pO2: 80-100 mmHg
8. Cardiac Markers
Markers for Myocardial Infarction
| Marker | Rises | Peaks | Normal |
|---|---|---|---|
| Troponin I/T | 3-6 hr | 12-24 hr | 7-14 days |
| CK-MB | 3-8 hr | 12-24 hr | 2-3 days |
| Myoglobin | 1-4 hr | 6-9 hr | 24 hr |
Key Points:
- • Troponin: Most specific and sensitive for cardiac damage
- • High-sensitivity troponin (hs-cTn): Earlier detection
- • BNP/NT-proBNP: Heart failure marker, not MI
Key Takeaways
- ✓HbA1c ≥6.5% or FBS ≥126 mg/dL = Diabetes diagnosis
- ✓LDL = TC - HDL - (TG/5) - only valid if TG <400
- ✓ALT is most liver-specific; AST:ALT >2 suggests alcohol
- ✓BUN/Cr >20:1 = prerenal azotemia; <10:1 = intrarenal
- ✓Troponin is the gold standard for MI diagnosis